Table 1.
Characteristic |
N (%) or mean±SD |
OS P value |
PFS P value |
---|---|---|---|
Age at HIPEC surgery | 52.2±10.5 | 0.842 | 0.226 |
Sex | 0.482 | 0.652 | |
Women | 14 (52) | ||
Men | 13 (48) | ||
Race | 0.341 | 0.998 | |
White | 23 (85) | ||
African-American | 4 (15) | ||
Primary disease site | 0.028 | 0.009 | |
Appendiceal | 14 (52) | ||
Colorectal | 13 (48) | ||
ECOG performance status | 0.914 | 0.880 | |
0 | 13 (48) | ||
1 | 9 (33) | ||
2 | 5 (19) | ||
Type of resection | 0.062 | 0.008 | |
R0, R1 | 13 (48) | ||
R2 | 14 (52) |
SDstandard deviation, OSoverall survival, PFSprogression-free survival, HIPEC hyperthermic intraperitoneal chemotherapy, ECOG Eastern Co-operative Oncology Group